Compounds for Modulating Tlr2

The present invention is directed to methods, kits, and uses of inhibitors of LCMV mediated NF-?B activation to treat viral infections and inflammatory conditions.

Patents:
WO 2,011,062,955

Inventor(s): FINBERG ROBERT W [US]; KURT-JONES EVELYN A [US]; ZHOU SHENGHUA [US]

Type of Offer: Sale